1. Home
  2. RDWR vs XNCR Comparison

RDWR vs XNCR Comparison

Compare RDWR & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Radware Ltd.

RDWR

Radware Ltd.

HOLD

Current Price

$29.47

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Xencor Inc.

XNCR

Xencor Inc.

HOLD

Current Price

$19.45

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RDWR
XNCR
Founded
1996
1997
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
RDWR
XNCR
Price
$29.47
$19.45
Analyst Decision
Buy
Buy
Analyst Count
2
9
Target Price
$32.50
$22.33
AVG Volume (30 Days)
213.0K
1.0M
Earning Date
05-07-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.36
EPS
N/A
N/A
Revenue
N/A
$125,576,000.00
Revenue This Year
$10.65
N/A
Revenue Next Year
$8.62
$4.80
P/E Ratio
$59.76
N/A
Revenue Growth
N/A
13.65
52 Week Low
$21.68
$6.92
52 Week High
$32.79
$21.26

Technical Indicators

Market Signals
Indicator
RDWR
XNCR
Relative Strength Index (RSI) 49.45 70.95
Support Level $23.45 $11.28
Resistance Level $32.36 N/A
Average True Range (ATR) 1.21 1.40
MACD -0.22 0.33
Stochastic Oscillator 28.96 72.67

Price Performance

Historical Comparison
RDWR
XNCR

About RDWR Radware Ltd.

Radware Ltd is a provider of application security and delivery solutions for multi-cloud environments. Its solutions secure the digital experience by providing infrastructure, application, and network protection and availability services to companies globally. Its solutions are deployed by, among others, enterprises, carriers, and cloud service providers. The company offers solutions in two main categories: Products offers a range of cloud-based security-as-a-service subscriptions, on-premises hardware and software products, and product subscriptions (or a combination of these) to customers; and Services offers managed services, professional services, technical support and training and certification to customers and partners.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: